NSI-189

NSI-189 is an experimental small molecule people discuss for emotional numbness, loss of pleasure and foggy thinking. Some describe feeling engaged again; others report little benefit, anxiety, fatigue or worse cognition. Stronger emotion can feel welcome or become difficult to manage.

What it is and why people discuss it

• An experimental non-peptide compound. NSI-189 is a small molecule studied for depression; ALTO-100 is its later development name. People seek relief from anhedonia—reduced pleasure—and emotional disconnection, alongside clearer thinking. Feeling better does not establish that brain tissue has regrown. Official context Official context Reddit
• Phosphate and freebase belong in the same discussion, with separate form labels. Kimera describes its material as NSI-189 phosphate. Freebase lacks that phosphate counterion; forum reports name both. Milligram amounts and absorption cannot be treated as interchangeable across forms or between swallowed and sublingual use, meaning under the tongue. Official context Reddit
• Amdiglurax is another name encountered in the literature. WHO lists that nonproprietary name for this chemical identity. A naming entry does not mean a medicine has been approved, and the clinical development name does not authenticate a commercial product. Official context Official context

Benefits people report

• Feeling something again. In the 2022 poll thread, one commenter welcomed crying at a show after a month. Another remembered increased emotionality but no permanent change. These accounts describe emotional responsiveness, not necessarily relief from depression. Reddit
• Subtle thinking changes, or little change. A two-month user described better task organization and memory retention. A later freebase commenter noticed little overall, with only possible cognitive benefit. Neither account used a controlled cognitive test. Reddit Reddit
• Renewed interest, rather than a general intelligence boost. The freebase logger described renewed enthusiasm and easier recall, including unpleasant memories. They did not report improved working memory; Concerta and phenibut co-use complicate attribution. Reddit

Nearest meaningful comparisons

• Pleasure, cognition and mood overlap across nootropics. 9-Me-BC is a useful neighboring topic for motivation and pleasure; Dihexa for memory and learning. NSI-189 brings a different chemical identity, emotional-response record and human depression trials to those discussions. Similar goals do not establish equal effects or a reason to combine substances. Official context Official context

Doses people discuss

These are self-reported amounts, not instructions or a safe range. mg means milligrams. Form, route and daily total matter.

• Oral phosphate: 40 mg total per day in one month-long account. That author did not get the hoped-for acute benefit. They also mentioned 80 mg experiments without a clear frequency, then a sublingual trial; those details do not establish an effective range. Reddit
• Sublingual phosphate: roughly 5–7 mg twice daily in another account. That implies about 10–14 mg per day, but the author estimated use from how long the powder lasted rather than weighing each dose. It is an imprecise report, not a verified smaller-dose standard or a conversion from oral use. Reddit
• Oral freebase: 80–110 mg each morning in one positive log. The author reached this after little response to initial 40 mg sublingual use, then a slight lift with 40 mg swallowed. Concerta and phenibut co-use prevent attributing the change to NSI-189 alone. This higher report is not an escalation guide. Reddit
• Other 2025 reports cannot be pooled into one range. One phosphate-preferring commenter compared 50–60 mg each morning with 40 mg twice daily (80 mg/day), without stating route. Another named about 20 mg sublingual, explicitly not phosphate, but omitted frequency and used several other compounds. Reddit

Half-life

• About 20 hours is repeated in community discussion. A 2025 discussion uses this estimate while interpreting research. It is study-derived talk, not a user measuring clearance, and it does not establish freebase or sublingual kinetics. The measured oral-phosphate context is separated below. Reddit

When people notice something

• Days to weeks, with nonresponse alongside them. A sublingual reporter described gradual mood changes followed by more activity; the poll’s emotional milestone occurred after a month. Another user lacked the hoped-for acute response after a month. Reddit Reddit
• An early mood change is also reported. The freebase log describes a small lift after switching to swallowed use on day four and more change from day five. Dose and route changed together, so this does not establish which mattered. Reddit

How long changes feel noticeable

• A few hours of stimulation is one phosphate commenter’s account. They also described stronger caffeine effects without clear concentration improvement. That brief feeling is different from emotional change across a course; no dependable single-dose benefit window is established. Reddit
• Persistence after stopping goes both ways. The 20-day NAC combination user reported returning to normal afterward. A different contributor described severe anxiety, low mood and poor sleep after stopping several months of use. Neither establishes a usual withdrawal pattern. Reddit
• Five days off is one favorable follow-up. The freebase author said mood remained similar five days after stopping. Recent phenibut use and changing life circumstances remained part of that account, so persistence is not proof of permanent repair. Reddit

Courses and breaks people describe

• Weeks and months are reported, without a tested reset calendar. Accounts include 20 days with NAC and two months of use. Longer-use accounts include serious adverse experiences. These reports establish neither a safe maximum nor a reliable break length. Reddit Reddit

Cautions that matter

• Greater emotional intensity can become destabilizing. One long-use contributor described impulsivity, irritability and difficulty functioning. Another reported psychosis and persistent tingling after prolonged use with several other compounds. The accounts are serious but cannot isolate NSI-189 as the cause. Reddit
• Cognitive worsening and fatigue are part of the record. A 2024 commenter recalled months of brain fog and poor short-term memory after about two weeks of use. In the poll, a commenter with chronic fatigue syndrome described early motivation followed by worsening fatigue. Product identity and medical causes were not independently assessed. Reddit Reddit
• Combining substances makes the story harder to interpret. NAC, caffeine, other nootropics and psychiatric medicines appear across accounts. Neither a favorable stack report nor a proposed protective supplement establishes interaction safety. These reports do not support treating a worsening reaction as proof of beneficial neurogenesis. Reddit Reddit
• Nausea and anxiety have uncertain causes in individual logs. In 2025, one person reported nausea after five days but also possible dehydration. A multi-compound user described early anxiety and brain fog alongside happier mood. Calling the fog neurogenesis was that user’s speculation, not a demonstrated explanation. Reddit

What the human research adds

• A small early trial measured oral-phosphate clearance. Fava and colleagues studied 24 people with major depression for 28 days, using oral phosphate at 40 mg once, twice or three times daily (40, 80 or 120 mg/day). They reported a 17.4–20.5-hour half-life and exploratory symptom signals; this small trial cannot validate freebase products or long-term use. Official context
• The larger depression trials did not confirm the main benefit. Neuralstem’s 220-person phase 2 study missed its primary depression endpoint at both tested amounts, despite improvements on some self-rated and attention/memory measures, but not Cogstate testing. Alto’s later 301-person ALTO-100 study also missed its primary endpoint and key secondary analyses in 2024. These failures matter when weighing confident antidepressant claims. Official context Official context
• Clinical tolerability is narrower than community safety. Alto reported headache, nausea and abnormal dreams at rates similar to placebo. Its 2026 update still described clinical development in bipolar depression. These reports neither establish long-term safety nor validate products sold under research labels. Official context Official context

What complete community accounts reveal

• Form preference is not a controlled comparison. A freebase user in 2024 noticed little while the creator described strong responses with phosphate, especially with other nootropics. A 2025 commenter also preferred phosphate. Different people, products and stacks cannot establish a superior form. Reddit Reddit
• A welcome opening does not tell the whole story. One prolonged-use account includes emotional benefit, tingling and psychosis with multiple co-exposures. Its follow-ups are one story; a DMT-like description was clarified as a comparison, not DMT consumption. Reddit
• The poll is a set of experiences, not a success rate. Its visible comments include emotional reconnection, fatigue and no lasting effect. Vote totals were unavailable on access, so the poll cannot support a numerical estimate of benefit or harm. Reddit